Deka Biosciences, Inc. (Deka), a biotech company focused on developing novel cytokine therapies to treat cancer and inflammatory diseases, announced the submission of an...
TG Therapeutics, Inc. announced the U.S. Food and Drug Administration (FDA) has approved BRIUMVI, for the treatment of relapsing forms of multiple sclerosis (RMS),...
BrainStorm Cell Therapeutics Inc., a leading developer of adult stem cell therapeutics for neurodegenerative diseases, announced that the U.S. Food and Drug Administration (FDA)...
PolarityTE, Inc., a biotechnology company developing regenerative tissue products and biomaterials announced that it signed a non-binding letter of intent (the "LOI") with Michael...
